Temporal, diagnostic, and tissue-specific regulation of NRG3 Isoform expression in human brain development and affective disorders

American Journal of Psychiatry

Volumn 174, Issue 3, 2017, Pages 256-265

  Paterson, Clare ^a   Wang, Yanhong ^a   Hyde, Thomas M ^a   Weinberger, Daniel R ^a   Kleinman, Joel E ^a   Law, Amanda J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ISOPROTEIN; NEUREGULIN 3; NEUROTROPHIN; UNCLASSIFIED DRUG; NEU DIFFERENTIATION FACTOR; NRG3 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ARTICLE; BIPOLAR DISORDER; BRAIN DEVELOPMENT; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DIAGNOSTIC TEST; DNA SYNTHESIS; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; GENOTYPE; HEREDITY; HUMAN; HUMAN TISSUE; LIFESPAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MOLECULAR MECHANICS; MOOD DISORDER; NEOCORTEX; NEUROLOGIC DISEASE; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PSYCHIATRIC TREATMENT; RNA ISOLATION; SCHIZOPHRENIA; TISSUE SPECIFICITY; ADOLESCENT; ADULT; AGED; COHORT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIPOLAR DISORDER; BLOTTING, WESTERN; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUREGULINS; POLYMORPHISM, GENETIC; PREFRONTAL CORTEX; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 85014469278     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2016.16060721     Document Type: Article

References (53)

1. Balciuniene J, Feng N, Iyadurai K, et al: Recurrent 10q22-q23 deletions: A genomic disorder on 10q associated with cognitive and behavioral abnormalities. Am J Hum Genet 2007; 80: 938-947
2. Faraone SV, Hwu HG, Liu CM, et al: Genome scan of Han Chinese schizophrenia families from Taiwan: Confirmation of linkage to 10q22.3. Am J Psychiatry 2006; 163: 1760-1766
3. Fallin MD, Lasseter VK, Wolyniec PS, et al: Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet 2003; 73: 601-611
4. Sonuga-Barke EJ, Lasky-Su J, Neale BM, et al: Does parental expressed emotion moderate genetic effects in ADHD? an exploration using a genome wide association scan. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1359-1368
5. Xu B, Woodroffe A, Rodriguez-Murillo L, et al: Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc Natl Acad Sci USA 2009; 106: 16746-16751
6. Meier S, Strohmaier J, Breuer R, et al: Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol 2013; 16: 549-556
7. Kao WT, Wang Y, Kleinman JE, et al: Common genetic variation in neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci USA 2010; 107: 15619-15624
8. Morar B, Dragovi-c M, Waters FA, et al: Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. Mol Psychiatry 2011; 16: 860-866
9. Chen PL, Avramopoulos D, Lasseter VK, et al: Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. Am J Hum Genet 2009; 84: 21-34
10. Wang KS, Xu N, Wang L, et al: NRG3 gene is associated with the risk and age at onset of Alzheimer disease. J Neural Transm (Vienna) 2014; 121: 183-192
11. Wang YC, Chen JY, Chen ML, et al: Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population. Biol Psychiatry 2008; 64: 1093-1096
12. Tost H, Callicott JH, RasettiR, et al: Effects of neuregulin 3 genotype on human prefrontal cortex physiology. J Neurosci 2014; 34: 1051-1056
13. Carteron C, Ferrer-Montiel A, Cabedo H: Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J Cell Sci 2006; 119: 898-909
14. Assimacopoulos S, Grove EA, Ragsdale CW: Identification of a Pax6-dependent epidermal growth factor family signaling source at the lateral edge of the embryonic cerebral cortex. J Neurosci 2003; 23: 6399-6403
15. Loos M, Mueller T, Gouwenberg Y, et al: Neuregulin-3 in the mouse medial prefrontal cortex regulates impulsive action. Biol Psychiatry 2014; 76: 648-655
16. Paterson C, Law AJ: Transient overexposure of neuregulin 3 during early postnatal development impacts selective behaviors in adulthood. PLoS One 2014; 9: E104172
17. Turner JR, Ray R, Lee B, et al: Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Mol Psychiatry 2014; 19: 801-810
18. Zeledón M, Eckart N, Taub M, et al: Identification and functional studies of regulatory variants responsible for the associationofNRG3 with a delusion phenotype in schizophrenia. Mol Neuropsychiatry 2015; 1: 36-46
19. Zhang D, Sliwkowski MX, Mark M, et al: Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci USA 1997; 94: 9562-9567
20. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium: Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015; 18: 199-209
21. Gulsuner S, Walsh T, Watts AC, et al: Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013; 154: 518-529
22. Birnbaum R, Jaffe AE, Hyde TM, et al: Prenatal expression patterns of genes associated with neuropsychiatric disorders. Am J Psychiatry 2014; 171: 758-767
23. Xu B, Ionita-Laza I, Roos JL, et al: De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet 2012; 44: 1365-1369
24. Lee SH, Ripke S, Neale BM, et al: Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013; 45: 984-994
25. Jenkins AK, Paterson C, Wang Y, et al: Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging. Mol Psychiatry 2016; 21: 701-706.
26. Law AJ, Weickert CS, Webster MJ, et al: Changes in NMD Areceptor subunit mRNAs and cyclophilin mRNA during development of the human hippocampus. Ann N Y Acad Sci 2003; 1003: 426-430
27. Paterson C, Wang Y, Kleinman JE, et al: Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development. Am J Psychiatry 2014; 171: 979-989
28. Law AJ, Kleinman JE, Weinberger DR, et al: Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 2007; 16: 129-141
29. Tan W, Wang Y, Gold B, et al: Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem 2007; 282: 24343-24351
30. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-408
31. Stead JD, Neal C, Meng F, et al: Transcriptional profiling of the developing rat brain reveals that the most dramatic regional differentiation in gene expression occurs postpartum. J Neurosci 2006; 26: 345-353
32. Tau GZ, Peterson BS: Normal development of brain circuits. Neuropsychopharmacology 2010; 35: 147-168
33. Jaffe AE, Shin J, Collado-Torres L, et al: Developmental regulation of human cortex transcription and its clinical relevance at single base resolution. Nat Neurosci 2015; 18: 154-161
34. Silbereis JC, Pochareddy S, Zhu Y, et al: The cellular and molecular landscapes of the developing humancentral nervous system. Neuron 2016; 89: 248-268
35. Birnbaum R, Jaffe AE, Chen Q, et al: Investigation of the prenatal expression patterns of 108 schizophrenia-associated genetic loci. Biol Psychiatry 2015; 77: E43-e51
36. Jaffe AE, Gao Y, Deep-Soboslay A, et al: Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex. Nat Neurosci 2016; 19: 40-47
37. de Graaf-Peters VB, Hadders-Algra M: Ontogeny of the human central nervous system: what is happening when? Early Hum Dev 2006; 82: 257-266
38. Levitt P: Structural and functional maturation of the developing primate brain. J Pediatr 2003; 143(Suppl): S35-S45
39. Kostovic I, Goldman-Rakic PS: Transient cholinesterase staining in the mediodorsal nucleus of the thalamus and its connections in the developing human and monkey brain. J Comp Neurol 1983; 219: 431-447
40. Bora E, Yucel M, Pantelis C: Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009; 113: 1-20
41. Dell'Osso B, Cinnante C, Di Giorgio A, et al: Altered prefrontal cortex activity duringworkingmemorytask in bipolar disorder: A functional magnetic resonance imaging study in euthymic bipolar I and II patients. J Affect Disord 2015; 184: 116-122
42. Callicott JH, Mattay VS, Verchinski BA, et al: Complexity of prefrontal cortical dysfunction in schizophrenia: More than up or down. Am J Psychiatry 2003; 160: 2209-2215
43. Toulopoulou T, Goldberg TE, Mesa IR, et al: Impaired intellect and memory: A missing link between genetic risk and schizophrenia? Arch Gen Psychiatry 2010; 67: 905-913
44. Xu W, Cohen-Woods S, Chen Q, et al: Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med Genet 2014; 15: 2
45. Sanches M, KeshavanMS, BrambillaP, et al: Neurodevelopmentalbasis of bipolar disorder: A critical appraisal. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1617-1627
46. Ansorge MS, Hen R, Gingrich JA: Neurodevelopmental origins of depressive disorders. Curr Opin Pharmacol 2007; 7: 8-17
47. Gilmore JH, Shi F, Woolson SL, et al: Longitudinal development of cortical and subcortical gray matter from birth to 2 years. Cereb Cortex 2012; 22: 2478-2485
48. Fisher ML, Loukola A, Kaprio J, et al: Role of the neuregulin signaling pathway in nicotine dependence and co-morbid disorders. Int Rev Neurobiol 2015; 124: 113-131
49. Silberberg G, Darvasi A, Pinkas-Kramarski R, et al: The involvement ofErbB4with schizophrenia: Associationand expression studies. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 142-148
50. Joshi D, Fullerton JM, Weickert CS: Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia. J Psychiatr Res 2014; 53: 125-132
51. Chung DW, Volk DW, Arion D, et al: Dysregulated ErbB4 splicing in schizophrenia: Selective effects on parvalbumin expression. Am J Psychiatry 2016; 173: 60-68
52. Law AJ, Wang Y, Sei Y, et al: Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110d inhibition as a potential therapeutic strategy. Proc Natl Acad Sci USA 2012; 109: 12165-12170
53. Papaleo F, Yang F, Paterson C, et al: Behavioral, neurophysiological, and synaptic impairment in a transgenic neuregulin1 (NRG1-IV) murine schizophrenia model. J Neurosci 2016; 36: 4859-4875